drugclasses.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.
FDA Approves Yorvipath (palopegteriparatide) for the Treatment of Hypoparathyroidism in Adults
Ascendis Pharma A/S (Nasdaq: ASND) today announced that the U.S. Food & Drug Administration (FDA) has approved Yorvipath (palopegteriparatide; developed...
FDA Approves Enzeevu (aflibercept-abzv), a Biosimilar to Eylea
Basel, August 12, 2024 – Sandoz (SIX:SDZ/OTCQX:SDZNY), the global leader in generic and biosimilar medicines, today announced that the US Food and...
FDA Approves neffy (epinephrine nasal spray) Needle-Free Treatment for Type I Allergic Reactions, Including Anaphylaxis
ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect patients...
FDA Approves Lymphir (denileukin diftitox-cxdl) Immunotherapy for the Treatment of Adults with Relapsed or Refractory Cutaneous T-Cell Lymphoma
Citius Pharmaceuticals, Inc. (NASDAQ: CTXR) ("Citius", "Citius Pharma"), announced today that the U.S. Food and Drug Administration (FDA) has approved...
FDA Approves Zurnai (nalmefene hydrochloride) Auto-Injector for the Emergency Treatment of Known or Suspected Opioid Overdose
STAMFORD, Conn., August 7, 2024 – Purdue Pharma L.P. (“Purdue”) announced today that the U.S. Food and Drug Administration (FDA) approved...
FDA Approves Voranigo (vorasidenib) for the Treatment of Grade 2 IDH-Mutant Glioma
BOSTON, Mass. – August 6, 2024 – Servier today announced that the U.S. Food and Drug Administration (FDA) has approved Voranigo, an isocitrate...
GLP-1 RA Use Linked to Lower Rates of Hyperkalemia in Type 2 Diabetes
Treatment with glucagon-like peptide 1 receptor agonists (GLP-1 RAs) is associated with lower rates of hyperkalemia and a lower rate of renin-angiotensin...
Pump Use Linked to Significantly Longer Duration of Breastfeeding
Pump use is associated with longer breastfeeding duration, with the lowest risk for breastfeeding cessation seen for non-Hispanic Black and Native American...
Buprenorphine + Naloxone Safe for Opioid Addiction in Pregnancy
Pregnancies exposed to buprenorphine combined with naloxone have similar or more favorable neonatal and maternal outcomes as those exposed to buprenorphine...
Prevalence of Homebound 22 Percent in National Medicare Advantage Plan
In a national Medicare Advantage (MA) plan, the prevalence of homebound is 22 percent, and homebound status is independently associated with increased...
More Toddler Screen Time Brings More Tantrums, Study Finds
Using tablets as 'e-babysitters' for toddlers could lead to more tantrums, which in turn can have harried parents trying to calm a child by handing them...
Getting Fats From Plants Vs. Animals Boosts Your Life Span
A study of more than 400,000 people tracked for up to 24 years finds that those who got their dietary fat from plants versus animals had significantly...
FDA Says No to MDMA as Therapy for PTSD
Advocates for the use of the psychedelic drug MDMA (midomafetamine) to treat mental health conditions were delivered a setback on Friday after the U.S....
Brain Study Shows How Classical Music Lifts Your Mood
Does listening to classical music make you feel sublime? A new study suggests there might be a scientific reason for that: Researchers discovered that...
Lykos Therapeutics Announces Complete Response Letter for Midomafetamine Capsules for PTSD
Lykos Therapeutics ("Lykos"), a company dedicated to transforming mental healthcare, announced that the U.S. Food and Drug Administration ("FDA") has issued...
First Patients Enrolled in US Pivotal Study of AI-Based Image Analysis Module for Lung Cancer
SANTA CLARA, Calif., Aug. 9, 2024. Invenio Imaging, a leader in intraoperative fresh tissue imaging and artificial intelligence (AI), announced today the...
WestGene to Advance Clinical Trials Following Dual IND Approvals for World's First EB Virus-Related mRNA Therapeutic Cancer Vaccine
CHENGDU, China, Aug. 8, 2024. WestGene Biopharma is proud to announce that its mRNA therapeutic cancer vaccine, WGc-043, has received dual IND approvals...
B. Braun Issues Voluntary Nationwide Recall of 0.9% Sodium Chloride for Injection USP 1000 mL in E3 Containers Due to the Potential for Particulate Matter and Leakage
BETHLEHEM, PA - August 8, 2024 – B. Braun Medical Inc. (B. Braun), is voluntarily recalling two (2) lots of 0.9% Sodium Chloride for Injection USP...
Hardy Bacteria Are Surviving in Your Microwave
Bacteria can adapt to a wide range of hostile environments, surviving and even thriving in marine oil spills, ocean-borne plastic trash, industrial brownfields...
FDA Warns Consumers to Not Purchase or Use Unapproved Inhalant Products Marketed for Alertness and Energy Boosting
FDA is warning consumers to not purchase or use certain inhalants, which are unapproved drugs marketed to promote alertness and boost energy. These products...
Recently Added
Recently added consumer and prescribing information: Yorvipath, Crexont, Lymphir, Epysqli, Pyzchiva, Ahzantive, Ohtuvayre, Sofdra, Yimmugo, Iqirvo
For Consumers
- Cerner Multum Drug Information
- Micromedex Advanced Consumer
- Natural Product Information for the Consumer
For Professionals
- FDA Professional Information
- Professional Patient Advice
- ASHP Monographs (AHFS DI)
- Micromedex Carenotes
- Natural Product Information
For Researchers
Latest FDA New Drug Approvals
- Yorvipath Yorvipath (palopegteriparatide) is a parathyroid hormone analog (PTH(1-34)) indicated for the treatment of hypoparathyroidism in adults.
- Enzeevu Enzeevu (aflibercept-abzv) is a vascular endothelial growth factor (VEGF) inhibitor biosimilar to Eylea indicated for the treatment of...
- neffy neffy(R) (epinephrine) is an intranasal epinephrine formulation for the emergency treatment of allergic reactions (Type 1), including...
Drugs in Development (Not yet approved)
- Yutrepia Yutrepia (treprostinil) is an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) to...